Thiazolidinediones are peroxisome proliferator-activated receptor-gamma agonists used in type 2 diabetes that help differentiate the fat cells into smaller insulin-sensitive fat cells and help resolve NAFLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.